Treatment of Advanced Intrahepatic Cholangiocarcinoma
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Levamisole Hcl in the
treatment of patients with advanced intrahepatic cholangiocarcinoma.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Collaborators:
Anyang Tumor Hospital First Affiliated Hospital of Xinjiang Medical University Luoyang Central Hospital Nanyang Central Hospital pinmei Group General Hospital Sanmenxia Central Hospital Third People's Hospital of Jiaozuo